Qiu Y - Search Results

1

MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.

Zhong X, Xie G, Zhang Z, Wang Z, Wang Y, Wang Y, Qiu Y, Li L, Bu H, Li J, Zheng H. Zhong X, et al. Among authors: qiu y. Oncotarget. 2016 Sep 20;7(38):61166-61182. doi: 10.18632/oncotarget.11278. Oncotarget. 2016. PMID: 27533459 Free PMC article.

2

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis.

Deng L, Lei Q, Wang Y, Wang Z, Xie G, Zhong X, Wang Y, Chen N, Qiu Y, Pu T, Bu H, Zheng H. Deng L, et al. Among authors: qiu y. Oncotarget. 2017 Oct 6;8(65):108712-108725. doi: 10.18632/oncotarget.21561. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312562 Free PMC article.

3

Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy.

Yang L, Zhong X, Pu T, Qiu Y, Ye F, Bu H. Yang L, et al. Among authors: qiu y. World J Surg Oncol. 2018 Mar 7;16(1):51. doi: 10.1186/s12957-018-1332-7. World J Surg Oncol. 2018. PMID: 29514654 Free PMC article.

4

Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.

Deng L, Chen J, Zhong XR, Luo T, Wang YP, Huang HF, Yin LJ, Qiu Y, Bu H, Lv Q, Zheng H. Deng L, et al. Among authors: qiu y. PLoS One. 2015 Mar 27;10(3):e0120511. doi: 10.1371/journal.pone.0120511. eCollection 2015. PLoS One. 2015. PMID: 25816324 Free PMC article.

5

The Presence of EpCAM(-)/CD49f(+) Cells in Breast Cancer Is Associated with a Poor Clinical Outcome.

Ye F, Qiu Y, Li L, Yang L, Cheng F, Zhang H, Wei B, Zhang Z, Sun L, Bu H. Ye F, et al. Among authors: qiu y. J Breast Cancer. 2015 Sep;18(3):242-8. doi: 10.4048/jbc.2015.18.3.242. Epub 2015 Sep 24. J Breast Cancer. 2015. PMID: 26472974 Free PMC article.

6

ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome.

Qiu Y, Pu T, Guo P, Wei B, Zhang Z, Zhang H, Zhong X, Zheng H, Chen L, Bu H, Ye F. Qiu Y, et al. Exp Mol Pathol. 2016 Feb;100(1):145-50. doi: 10.1016/j.yexmp.2015.11.032. Epub 2015 Dec 11. Exp Mol Pathol. 2016. PMID: 26687806

7

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

Ye F, Zhong X, Qiu Y, Yang L, Wei B, Zhang Z, Bu H. Ye F, et al. Among authors: qiu y. J Breast Cancer. 2017 Jun;20(2):142-149. doi: 10.4048/jbc.2017.20.2.142. Epub 2017 Jun 26. J Breast Cancer. 2017. PMID: 28690650 Free PMC article.

8

Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.

Guo P, Pu T, Chen S, Qiu Y, Zhong X, Zheng H, Chen L, Bu H, Ye F. Guo P, et al. Among authors: qiu y. Oncol Lett. 2017 Dec;14(6):6562-6570. doi: 10.3892/ol.2017.7051. Epub 2017 Sep 25. Oncol Lett. 2017. PMID: 29181099 Free PMC article.

9

A multiple breast cancer stem cell model to predict recurrence of T_1-3, N₀ breast cancer.

Qiu Y, Wang L, Zhong X, Li L, Chen F, Xiao L, Liu F, Fu B, Zheng H, Ye F, Bu H. Qiu Y, et al. BMC Cancer. 2019 Jul 24;19(1):729. doi: 10.1186/s12885-019-5941-5. BMC Cancer. 2019. PMID: 31340763 Free PMC article.

10

Long term prognosis of ductal carcinoma in situ with microinvasion: a retrospective cohort study.

Pu T, Zhong X, Deng L, Li S, Qiu Y, Liu Y, Zheng H, Ye F, Bu H. Pu T, et al. Among authors: qiu y. Int J Clin Exp Pathol. 2018 May 1;11(5):2665-2674. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938381 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,326 results

Search Page

Filters